NKNikolai E. Kudashkin

Nikolai E. Kudashkin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nikolai E. Kudashkin has a total of 213 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Risk factors and clinical significance of diabetes mellitus developed after pancreaticoduodenectomy for pancreatic cancer

    by V. I. Egorov, A. G. Kotelnikov, Yu. I. Patyutko, F. Sh. Akhmetzyanov, A. N. Polyakov, N. E. Kudashkin, В. И. Егоров, А. Г. Котельников, Ю. И. Патютко, Ф. Ш. Ахметзянов, et al.

    BACKGROUND: Diabetes mellitus (DM) is a clinically significant long-term complication of pancreatoduodenectomy (PD); however, its incidence, risk factors for its development, and its impact on oncological outcomes remain insufficiently studied. AIM: To evaluate risk factors for diabetes mellitus in patients undergoing pancreatoduodenectomy and to determine its clinical significance. MATERIALS AND METHODS: A two-center retrospective cohort study was conducted, including 544 patients who underwent PD between 2011 and 2024. Clinical, demographic, intraoperative, and morphological parameters were analyzed. Univariate and multivariate regression analyses were used to identify predictors of DM and to assess survival. The predictive performance of the model was evaluated using ROC analysis. RESULTS: The overall incidence of DM among patients without pre-existing diabetes mellitus was 15.3% (83/544). Independent predictors for the development of DM were: age 67 years and older (OR 1.069; 95% CI: 1.029–1.110; p=0.001), stable angina pectoris (OR 2.554; 95% CI: 1.172–5.562; p=0.018), diameter of the Wirsung duct (≥0.5 cm) (OR 5.84; 95% CI: 1.399–24.45; p=0.016), complications of Clavien–Dindo grade ≥ IIIA (OR 8.9; 95% CI: 3.9–20.3; pCONCLUSION: Diabetes mellitus following pancreatoduodenectomy for pancreatic head and periampullary cancers is a relatively uncommon (15.3%) but clinically significant complication. Preoperative assessment of the risk for this complication and careful postoperative metabolic monitoring are necessary.

  • Open Access

    Surgical outcomes in patients with pancreatic body and tail cancer invading the main veins

    by M. G. Abgaryan, А. Г. Котельников, S. N. Berdnikov, D. V. Podluzhny, A. E. Kalinin, O. A. Egenov, N. E. Kudashkin

    The aim of the study was to demonstrate the safety and satisfactory outcomes of surgical treatment in patients with ductal cancer of the body and tail of the pancreas with invasion of the main veins using distal subtotal resection of the pancreas with resection of the superior mesenteric and / or portal veins. Materials and methods: Distal subtotal resection of the pancreas with resection of the superior mesenteric and / or portal veins was performed in 29 patients with ductal cancer of the body and tail of the pancreas. Parietal resection of the main veins with a length of 1.0 to 3.0 cm using a parietal suture was performed in 15 (51.7%) patients, and circular resection with a length of 1.5 to 5.0 cm was carried out in 14 (48.3%) patients. In the circular resection subset, 11 people had an end-to-end anastomosis, 2 had plastic surgery using a Gore-Tex synthetic graft, and 1 underwent an autologous vein plastic surgery. Compression of the portal vein during surgery lasted from 10 to 16 minutes with the creation of a direct end-to-end anastomosis and from 12 to 27 minutes with the use of a graft. Damage from the tumor to neighboring organs required a liver resection in 1 (3.5%) patient, wedge resection of the stomach wall in 3 (10.3 %) patients, adrenalectomy in 2 (6.9 %) subjects, small intestine resection in 2 (6.9 %) patients, one diaphragm resection, one nephrectomy, and one hemicolectomy. The duration of the operations ranged from 2 to 6.5 hours, and the volume ofblood loss ranged from 300 mL to 5.6 L. Results: R0 surgery was performed in 89.6 % of patients, R1 in 6.9 %, and R2 surgery in 3.5% of cases. Histopatho-logical examination of the surgical material revealed retroperitoneal invasion in 69.0% of patients, perineural invasion in 65.5%, and invasion of the superior mesenteric and/ or portal veins in 55.2% of cases. Complications occurred in 51.7% of patients, the incidence of Clavien-Dindo Grade III or higher complications was 34.5%. All complications were controlled with conservative treatment; there were no deaths. Long-term treatment outcomes: The one- and three-year overall survival rates were 74.6% and 14.9%, respectively (median 14.6 months), the progression-free survival rates were 31.0% and 15.5%, respectively (median 8.0 months). A comparison of results in 26 patients who underwent R0 surgery and 3 patients who underwent R+ surgery did not reveal statistically significant differences. Conclusion: Distal subtotal resection of the pancreas with resection of the superior mesenteric and / or portal veins is relatively safe and helps to improve the duration and quality of life of patients with ductal cancer of the body and tail of the pancreas.

  • Infusion therapy and acinar component of the pancreas as predictors of pancreatic fistula in pancreatoduodenectomy

    by O.S. Vlasenko, A.N. Polyakov, S.O. Matveeva, N.E. Kudashkin, O.A. Egenov, V.YU. Salkova, D.V. Podluzhny, A.V. Sytov

    Objective. To evaluate the effect of first-day infusion and pancreatic acinar structures on the incidence of postoperative pancreatic fistulas (POPF) and complications after pancreatoduodenectomy. Material and methods. A retrospective study included patients who underwent pancreatoduodenectomy in 2024. Results. There were 79 patients: group 1 (n=38) — infusion ≥4.5 ml/kg/h on day 1, group 2 (n=41) — infusion <4.5 ml/kg/h. The median of acinar structures was 65%. POPF were found in 23.6% (n=9) and 53.6% (n= 22) of patients, respectively (p=0.021). POPF type B prevailed (21.0% (n=8) and 51.2% (n=21) of patients, respectively, p=0.033). Clavien-Dindo grade III—V complications occurred in 26.3% (n=10) and 58.5% (n=24) of patients, respectively (p=0.022). Multifactorial analysis showed that daily infusion <4.5 ml/kg/h (OR=3.938; 95% CI 1.461—10.614; p=0.025) and acinar structures ≥65% (OR=12.889; 95% CI 4.285—38.772; p=0.001) were predictors of type B POPF. Acinar structures ≥65% were predictors of Clavien-Dindo grade ≥III complications (OR=11.487; 95% CI 3.853—34.243; p=0.003). Conclusion. Daily infusion <4.5 ml/kg/h (p=0.025) and acinar structures ≥65% (p=0.001) increase the incidence of type B POPF after pancreatoduodenectomy. Acinar structures ≥65% increase the incidence of Clavien-Dindo ≥ grade III complications (p=0.003).


  • Open Access

    Tumor location and histogenesis as risk factors for early complications and mortality following multivisceral surgical procedures with pancreatoduodenectomy

    by V. I. Egorov, А. Г. Котельников, Yu. I. Patyutko, F. Sh. Akhmetzyanov, N. E. Kudashkin, A. N. Polyakov, D. M. Ruvinskiy, D. V. Podluzhny, Ю. И. Патютко

    Aim. To investigate the role of tumor localization and histogenesis as risk factors for postoperative complications and mortality following multivisceral surgical procedures involving pancreaticoduodenectomy.Materials and Methods. This study included all patients (n = 251) who underwent multivisceral surgery with pancreaticoduodenectomy for tumors of various localizations at two medical institutions.Results. Comparative analysis of pancreatic parenchymal density revealed statistically significant differences between pancreatic cancer and cancer of the major duodenal papilla (p = 0.012), distal common bile duct cancer (p = 0.040), duodenal tumors (p < 0.001), secondary pancreatic tumors (p < 0.001), colorectal cancer (p < 0.001), renal cancer (p = 0.027), and gastric cancer (p < 0.001). Statistically significant differences were also observed in the following pairwise comparisons: major duodenal papilla cancer vs. colorectal cancer (p = 0.010); neuroendocrine tumor of the pancreatic head vs. colorectal cancer (p < 0.001); pancreatic neuroendocrine tumor vs. gastric cancer (p = 0.006). For pancreatic duct diameter, significant differences were found between duodenal tumors and pancreatic cancer (p = 0.016), colorectal cancer and pancreatic cancer (p < 0.001), gastric cancer and pancreatic cancer (p = 0.016). The overall rate of postoperative complications in the study group was 65.7% (n = 165), with a mortality rate of 7.2% (n = 18). The likelihood of developing a postoperative pancreatic fistula was significantly higher in patients with distal common bile duct cancer (AOR 5.9; 95% CI: 1.4–24.6, p = 0.015), secondary malignancies of the pancreatic head (AOR 4.7; 95% CI: 1.06–21.0, p = 0.041), and gastric cancer (AOR 2.8; 95% CI: 1.048–7.691, p = 0.040). The risk of dehiscence of pancreatic-digestive anastomosis significantly increased in patients with distal common bile duct cancer (AOR 7.8; 95% CI: 1.7–35.05, p = 0.007). In patients with secondary malignancies of the pancreatic head, postoperative mortality was significantly higher (AOR 9.7; 95% CI: 1.79–52.8, p = 0.008).Conclusion. Tumor localization and histogenesis may serve as independent predictors of early outcomes following multivisceral surgery with pancreatoduodenectomy. Cancer of the pancreatic head generally has the most favorable prognosis among pancreatic tumors, and its location is associated with a lower risk of postoperative complications. In contrast, surgeries for distal common bile duct cancer, metastatic lesions of the pancreatic head, and gastric cancer are associated with significantly worse short-term outcomes.

  • Multivisceral surgeries with pancreatoduodenectomy for gastric cancer: immediate and long-term results

    by V.I. Egorov, A.G. Kotelnikov, Yu.I. Patyutko, F.SH. Akhmetzyanov, D.V. Podluzhny, A.N. Polyakov, N.E. Kudashkin, N.T. Shaikhutdinov

    Objective. To study the immediate and long-term results of multivisceral surgeries with pancreaticoduodenectomy for gastric cancer. Material and methods. The 1st group included 24 patients who underwent multivisceral surgeries with pancreaticoduodenectomy for gastric cancer with pancreatic head and/or duodenum invasion. The 2nd group included 60 patients with gastric cancer who underwent partial resection of the pancreatic head and/or duodenum rather pancreaticoduodenectomy. Results. ASA class III was observed in 10 (41.7%) out of 24 patients in the 1st group and in 12 (20.0%) out of 60 patients in the 2nd group (p=0.041). In group 2, there were no cases of vein invasion (0 versus 12.5%; p=0.021). In group 1, Clavien-Dindo grade ≥3 complications were more common (10 (41.7%) vs. 14 (23.3%) cases, p=0.005). Moreover, pancreatic fistulas of all classes were more common (9 (37.5%) vs. 9 (15.0%) cases, p=0.023). Median overall survival was 15 and 14 months, respectively. Overall five-year survival was 24.1% (95% CI 7.8—45.2) and 8.2% (95% CI 2.3—18.9%), respectively (p=0.483). Locoregional recurrence was more common in the 2nd group (23 (41.8%) out of 55 vs. 3 (13.6%) out of 23 patients, p=0.018). In the 1st group, median overall survival without adjuvant chemotherapy was 13 months (95% CI 5—17), in the group with adjuvant chemotherapy — 37 months (95% CI 14—64). Overall five-year survival was 7.7% (95% CI 5—29.2) and 50.0% (95% CI 13.7—78.5), respectively (p=0.003). Median overall survival in the 2nd group without adjuvant chemotherapy was 13 months (95% CI 5—17), in the 2nd group with chemotherapy — 17 months (95% CI 12—29; p=0.016). The risk of death in the 2nd group with chemotherapy was lower than in the 1st group without chemotherapy (OR 0.385; 95% CI 0.183—0.809; p=0.012). Multivariate analysis in the 1st group revealed that ASA class 3 negatively affected overall survival (OR 3.04; 95% CI 1.04—8.81; p=0.040). Multivariate analysis after combining both groups established that negative factors of long-term prognosis were female gender (OR 2.47; 95% CI 1.25—4.87; p=0.009), coronary artery disease (OR 3.44; 95% CI 1.16—10.17; p=0.025), locoregional recurrence (OR 2.49; 95% CI 1.13—5.50; p=0.024) and type B pancreatic fistula (OR 2.68; 95% CI 1.070—6.731; p=0.035). Positive factors were multivisceral surgeries with pancreaticoduodenectomy (OR 0.36; 95% CI 0.14—0.86; p=0.023) and adjuvant chemotherapy (OR 0.27; 95% CI 0.13—0.57; p<0.001). Conclusion. Multivisceral surgeries with pancreaticoduodenectomy for gastric cancer with pancreatic and/or duodenal invasion is justified in patients with ASA class 1—2 due to higher probability of adjuvant chemotherapy and better survival.


  • Late complications and quality of life after multivisceral surgeries with pancreatoduodenectomy

    by V.I. Egorov, A.G. Kotelnikov, Yu.I. Patyutko, D.V. Podluzhny, A.N. Polyakov, N.E. Kudashkin, E.N. Fayazov

    Objective. To investigate late complications after pancreatoduodenectomy (PD) as a part of multivisceral surgeries (MVS) and the impact of these interventions on the quality of life. Material and methods. Analysis of complications in long-term postoperative period included 776 patients (233 cases of MVS with PD (main group) and 543 cases of standard PD (comparison group)). Analysis of the quality of life included 58 patients from the main group and 67 patients from the comparison group. The quality of life was studied using the Russian-language versions of the EORTC QLQ-C30 and EORTC QLQ-PAN26 questionnaires. Results. There were no significant between-group differences in the incidence of long-term postoperative complications (26.2% versus 20.1%, p=0.059). Diabetes mellitus occurred in 26 (15.9%) and 57 (10.8%) patients, respectively (p=0.08). Malnutrition (10.3% versus 3%, p<0.001), cholangitis (7.3% versus 2.5%, p=0.003) and edema/ascites (7.3% versus 0.8%, p<0.001) were significantly more common in the main group. According to the EORTC QLQ-C30 scores in the main group, general health (58 (58 — 58) versus 66 (58 — 66), p<0.001, weak clinical significance) and physical functions (79.5 (73 — 89) versus 86 (73 — 93), p=0.04, weak clinical significance) were significantly worse, and weakness was more pronounced (22 (22 — 33) versus 11 (11 — 22), p<0.001, moderate clinical significance). According to the EORTC QLQ-PAN26 scores, weight loss (24.5 (16—33) versus 16 (0—16), p<0.001, weak clinical significance), weakness in arms and legs (16 (16—16) versus 0 (0—16), p<0.001, moderate clinical significance) and dry mouth (8 (0—16) versus 0 (0—16), p=0.004, weak clinical significance) were more common in the main group. Conclusion. MVS with PD is significantly more often accompanied by cholangitis and symptoms of alimentary failure in long-term period. This determines the worst quality of life after MVS with PD.

  • Open Access

    Possibilities of Multiparametric Ultrasound Navigation in Biopsies of Neuroendocrine Neoplasia of the Pancreas.

    by S. N. Berdnikov, M. G. Abgaryan, A. M. Belozerskikh, I. V. Pogrebnyakov, V. N. Sholokhov, N. E. Kudashkin, P. A. Tikhonov, M. S. Makhotina, А. Д. Кузьмин, A. S. Bredneva, et al.

    Purpose: Improved biopsy results of neuroendocrine neoplasia of the pancreas and neuroendocrine neoplasia of the gastrointestinal tract of other locations under ultrasound navigation. Materials and methods: The study included 56 CT scans with intravenous contrast and clinical and laboratory methods of examining neuroendocrine neoplasia of the pancreas. The results of biopsies of neuroendocrine neoplasia of the pancreas were analyzed under ultrasound navigation in the usual B-mode and in the B-mode with complex methods for determining the elasticity of pancreatic tumors (elastometry and elastography), doppler imaging and improved visualization in B-mode. Conclusion: Additional ultrasound techniques allow us to provide qualitative and quantitative criteria for the tumor structure, which technically allows us to obtain a high-quality biopsy and avoid unnecessary biopsies.

  • Open Access

    Refined Ultrasound Diagnostic Criteria for Budd–Chiari Syndrome in High-Grade Occlusive Thrombosis of the Inferior Vena Cava.

    by S. N. Berdnikov, M. G. Abgaryan, I. V. Pogrebnyakov, A. E. Kalinin, V. N. Sholokhov, N. E. Kudashkin, M. S. Makhotina, А. Д. Кузьмин, A. S. Bredneva, N. D. Nasonov, et al.

    Purpose: To improve the diagnostic efficacy of ultrasound (US) in detecting tumor thrombi in the inferior vena cava (IVC) and refine ultrasonographic criteria for Budd–Chiari syndrome (BCS) in patients with high-grade occlusive tumor thrombi of the IVC. Materials and methods: The study included 112 patients (36–78 years) with high-grade occlusive IVC thrombi. Inclusion Criteria: 1. Primary tumors (e.g., IVC leiomyosarcoma, renal cell carcinoma) associated with IVC thrombosis. 2. Instrumentally confirmed partial or complete occlusion of hepatic vein ostia. Ultrasound Protocol: B-mode imaging: Evaluation of thrombus echogenicity, structure, and extent; assessment of hepatic veins, IVC, and portal system. Doppler ultrasound: Analysis of blood flow direction and velocity in hepatic veins, IVC, and portal vein; diagnosis of hepatic vein occlusion. Liver elastometry: Fibrosis staging using METAVIR (F0–F4). Additional verification methods: correlation with computed tomography (CT) or magnetic resonance imaging (MRI) data and histopathological confirmation (in postoperative patients). Results: Absolute contraindications to surgery were identified in 6.25 % of patients (n = 7): Occlusive IVC thrombosis with impaired hepatic venous outflow. Hepatomegaly with structural parenchymal changes. METAVIR F4 fibrosis (cirrhosis). Decompensated portal hypertension (ascites, splenomegaly). In 93.75 % (n = 105), absence of cirrhosis enabled radical surgical intervention (tumor resection with thrombectomy). Elastometry confirmed a direct correlation between fibrosis severity and BCS progression (F4 fibrosis as a key predictor of non-operability). Conclusions: Refined ultrasound criteria for Budd–Chiari syndrome in patients with inferior vena cava (IVC) tumor thrombosis not only enhance diagnostic accuracy but also minimize the risk of unnecessary surgeries. Elastography and portal hemodynamic assessment are pivotal components of the diagnostic algorithm, significantly influencing clinical outcomes. Implementing these strategies into clinical practice will improve survival rates and reduce postoperative complication rates.


  • Pancreatoduodenalectomy with hemihepatectomy — analysis of clinical experience

    by V.I. Egorov, A.G. Kotelnikov, Yu.I. Patyutko, D.V. Podluzhnyi, A.N. Polyakov, N.E. Kudashkin

    Hepatopancreatoduodenalectomy is a complex and traumatic surgical intervention, which is accompanied by an extremely high frequency of postoperative complications and mortality, reaching 97.4% and 26%, respectively. Objective. To analyze the clinical experience of pancreaticoduodenal resections with hemihepatectomy for various malignant neoplasms. Material and methods. The analysis included seven patients who underwent pancreaticoduodenal resection with hemihepatectomy for various malignant tumors. Two patients had neuroendocrine tumors of the pancreatic head, 2 had bile duct cancer, 1 had renal cancer with synchronous metastases to the pancreatic head and liver, 1 had retroperitoneal sarcoma and 1 had cancer of the hepatic flexure of the colon. Results. Hepatopancreatoduodenalectomy were accompanied by a high frequency of postoperative complications of class 3 and higher according to Clavien-Dindo (85.7%). Three (42.9%) of seven patients developed type B pancreatic fistula. High frequency of intra-abdominal abscesses (28.6%), pneumonia (28.6%) and ulcerative gastric bleeding (28.6%) are noteworthy. Postoperative liver failure type A developed in three patients (42.9%). The operations were accompanied by a significant volume of blood loss with a median of 5500 ml. The median duration of surgery was 300 minutes. The median postoperative hospital stay was 29 days. Postoperative mortality was 14.3%. Conclusion. Hepatopancreatoduodenalectomy are extremely rare surgical interventions, which are accompanied by a high frequency of postoperative complications and mortality even if they are performed in large high-tech centers. Patients for these operations must undergo strict selection to reduce postoperative risks.

  • Open Access

    Multivisceral surgery for ductal adenocarcinoma of the pancreatic head: early and long-term outcomes

    by V. I. Egorov, А. Г. Котельников, Yu. I. Patyutko, F. Sh. Akhmetzyanov, D. V. Podluzhny, N. E. Kudashkin, A. N. Polyakov, D. M. Ruvinskiy, Ю. И. Патютко

    Aim. To evaluate the early and long-term outcomes of multivisceral surgery for ductal adenocarcinoma of the pancreatic head.Materials and methods. Group 1 (main group) included 63 patients who underwent multivisceral surgery for ductal adenocarcinoma of the pancreatic head. Group 2 (control group) consisted of 442 patients with ductal adenocarcinoma of the pancreatic head who underwent standard pancreatoduodenectomy. Patients with stage IV tumors were excluded.Results. Immediate outcomes were comparable between the groups, except for a higher incidence of intra-abdominal abscesses in Group 1 (12.7% vs. 2.1%; p < 0.001). Postoperative mortality differed insignificantly (6.3% vs. 4.3%; p = 0.465). The median overall survival in Group 1 was 22 months compared to 33 months in Group 2, and the 5-year overall survival rates were 9.1% and 20.4%, respectively (p = 0.001). The frequency of adjuvant chemotherapy administration (p = 0.285) and the median number of chemotherapy cycles (p = 0.446) differed insignificantly between the groups. The 5-year overall survival among patients who received adjuvant chemotherapy was 13.3% in Group 1 and 19.4% in Group 2. The median overall survival in these groups was 30 and 35 months, respectively (p = 0.108). In Group 2, the median overall survival without neoadjuvant chemotherapy was 35 months, compared to 31 months with neoadjuvant chemotherapy (p = 0.411).Conclusion. Multivisceral resections involving pancreatoduodenectomy for ductal adenocarcinoma of the pancreatic head are associated with comparable immediate outcomes to standard pancreatoduodenectomy without adjacent organ resection. These outcomes are comparable only when the procedures are performed in specialized centers and when adequate adjuvant chemotherapy is administered; without it, survival rates following multivisceral surgery were significantly lower. Indications for multivisceral procedures require a personalized approach that takes into account all prognostic factors.